Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-21

Clinical Trial Update: Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR) [Phase 1]

View source ↗

Summary

This is a Phase 1 drug-drug interaction study evaluating the pharmacokinetic interactions of GSK3640254 with darunavir/ritonavir and with etravirine; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK3640254
  • darunavir/ritonavir (darunavir/ritonavir)
  • etravirine (etravirine)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2023-08-21